BioTelemetry Stock News

MALVERN, Pa., April 27, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery...

Joe Capper became the CEO of BioTelemetry, Inc. (NASDAQ:BEAT) in 2010. This report will, first, examine the CEO...

Deutsche Bank says results will beat forecasts

TLDR: 'Supernatural' will make you want to work out often.

Stocks Slip Again on Oil Prices

BioTelemetry (BEAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BioTelemetry (BEAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

BioTelemetry Inc (NASDAQ:BEAT) was the recipient of a large decrease in short interest in the month of March. As of March 31st, there was short interest totalling 2,240,000 shares, a decrease of 16.6%

Nuveen Asset Management LLC trimmed its holdings in BioTelemetry Inc (NASDAQ:BEAT) by 0.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchang

Norges Bank purchased a new stake in shares of BioTelemetry Inc (NASDAQ:BEAT) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional

Zacks Investment Research downgraded shares of BioTelemetry (NASDAQ:BEAT) from a buy rating to a hold rating in a research report released on Wednesday, Zacks.com reports. According to Zacks, “BioTe

Cash, check, or Google Card?

Lot Sixteen adds 4 — Franchises lobby Treasury to change small business loan rules